Moreover, CCL5 and XCL1 produced by tumor-infiltrating NK cells and innate lymphoid cells promoted the recruitment and activation of XCR1+ cDC1s, fostering NK-cDC1 axis-related control of tumor growth [25, 185, 186]. The gene discussed is CCL5; the disease is neoplasm.